News | June 06, 2026
Alembic Pharma receives USFDA approval for Haloperidol tablets
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
Subscribe To Our Newsletter & Stay Updated
